Royalty Pharma plc (RPRX)

Sector:Health Care
Super Investor Stats:
Ownership count:3
Ownership rank:206
% of all portfolios:0.095%
Hold Price * :$28.29
History Portfolio Manager Activity Share change % change to portfolio ▲
Q3  2023
≡ Torray Funds Reduce 0.29% 1,182 0.01
≡ Viking Global Investors Reduce 3.93% 386,731 0.04
Q2  2023
≡ Viking Global Investors Reduce 12.08% 1,353,317 0.17
Q1  2023
≡ Torray Funds Reduce 0.14% 199 0.00
Q4  2022
≡ Torray Funds Reduce 1.19% 1,653 0.01
≡ Viking Global Investors Reduce 8.02% 873,083 0.17
Q3  2022
≡ Viking Global Investors Reduce 12.04% 1,489,100 0.28
Q2  2022
≡ Warren Buffett - Berkshire Hathaway Sell 100.00% 1,496,372 0.02
Q1  2022
≡ Torray Funds Reduce 4.26% 5,871 0.04
≡ Warren Buffett - Berkshire Hathaway Reduce 82.70% 7,151,896 0.10
Q4  2021
≡ Warren Buffett - Berkshire Hathaway Reduce 34.21% 4,497,634 0.05
Q2  2021
≡ Lee Ainslie - Maverick Capital Sell 100.00% 7,342 0.00
Q1  2021
≡ Viking Global Investors Reduce 9.85% 225,247 0.03
Q3  2020
≡ Viking Global Investors Reduce 22.54% 566,921 0.09

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.